Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
3.180
-0.010 (-0.31%)
Nov 20, 2024, 4:00 PM EST - Market closed
Marker Therapeutics Market Cap
Marker Therapeutics has a market cap or net worth of $28.37 million as of November 21, 2024. Its market cap has increased by 5.48% in one year.
Market Cap
28.37M
Enterprise Value
19.37M
1-Year Change
5.48%
Ranking
Category
Stock Price
$3.18
Market Cap Chart
Since November 8, 2016, Marker Therapeutics's market cap has decreased from $45.80M to $28.37M, a decrease of -38.05%. That is a compound annual growth rate of -5.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 28.50M | -41.72% |
| Dec 29, 2023 | 48.90M | 120.27% |
| Dec 30, 2022 | 22.20M | -71.86% |
| Dec 31, 2021 | 78.90M | 13.36% |
| Dec 31, 2020 | 69.60M | -47.15% |
| Dec 31, 2019 | 131.70M | -47.70% |
| Dec 31, 2018 | 251.80M | 509.69% |
| Dec 29, 2017 | 41.30M | 27.08% |
| Dec 30, 2016 | 32.50M | -29.04% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Passage Bio | 29.77M |
| IRIDEX | 29.61M |
| NeurAxis | 29.51M |
| Tonix Pharmaceuticals Holding | 29.06M |
| Impact BioMedical | 28.87M |
| OneMedNet | 28.29M |
| ImmuCell | 28.20M |
| Nortech Systems | 28.12M |